Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma or the bladder

Journal of Clinical Pathology

Volumn 59, Issue 1, 2006, Pages 83-88

  Quintero, A ^b   Alvarez Kindelan, J ^b   Luque, R J ^c   Gonzalez Campora, R ^d   Requena, M J ^b   Montironi, R ^e   Lopez Beltran, A ^a,b  

^a Universidad de Cordoba   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c University Hospital   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TISSUE SPECIFICITY; TUMOR RECURRENCE; TUMOR VOLUME; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 30444455923     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022939     Document Type: Article

References (35)

1. Epstein JI Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-48.
2. Helpap BBJS, Hamilton PW, Muzzonigro G, et al. Molecular pathology of non-invasive urothelial carcinomas (part I). Virchows Arch 2003;442:309-16.
3. Holmonq S, Hedelin H, Anderstrom C, et al. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999;162:702-7.
4. Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 2004;46:170-6.
5. Sauter G, Algaba F, Amin MB, et al. Non invasive urothelial neoplasias. WHO classification of non-invasive papillary urothelial tumors. In, Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs Lyon, IARCC Press, 2004.
6. Pich A, Chiusa L, Formiconi A, et al. Proliferative activity is the most significant predictor of recurrence in non-invasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002;15:784-90.
7. Van Rhijn Bas WG, Vis AN, van der Kwast TH, et al. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 2003;21:1912-21.
8. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, et al. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1 and cyclin D3) and proliferation index (ki67-MIB1). Eur Urol 2004;45:606-12.
9. Bol MGW, Baak JPA, van Diermen B, et al. Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks. J Clin Pathol 2003;56:447-52.
10. Cina SJ, Lancaster-Weiss K, Lecksell K, et al. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasia. Arch Pathol Lab Med 2001;125:646-51.
11. Helpap B, Köllermann J. Proliferative pattern of exophytic and superficially invasive and noninvasive low-grade urothelial carcinomas. Hum Pathol 1999;30:145-50.
12. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol 2004;122:444-52.
13. van Rhijn BW, Montironi R, Zwarthoff EC, et al. Frequent FGFR3 mutations in urothelial papilloma. J Pathol 2002;198:245-51.
14. Dybowski BKJ, Rembiszewska A, Pykalo R, et al. p27kip1 and ki-67 expression analysis in transitional cell carcinoma of the bladder. Urol Res 2003;31:397-401.
15. Gerdes J, Becker M, Keyt G, et al. Immunohistochemical detection of tumor growth fraction (Ki-67 antigen) in formalin fixed and routinely processed tissue. J Pathol 1992;168:85-7.
16. Liukkonen T, Rajala P, Raitanen M, et al. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder group. Eur Urol 1999;36:393-400.
17. Mulder AH, Van Hootegem JC, Sylvester R, et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 1992;166:37-43.
18. Oosterhuis JW, Schapers RF, Janssen-Heijrien MLG, et al. Mib-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 2000;88:2598-605.
19. Sarkis AS, Dalbagni G, Cordon-Cardo C, et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 1993;85:53-9.
20. Slaton JW, Benedict W, Dinney CP. p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 2001;57:852.
21. Lopez-Beltran A, Cheng L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 2003;35:484-91.
22. Greene FL, Page D, Fleming ID, et al. AJCC cancer staging manual. New York Berlin Heidelberg: Springer-Verlag, 2002.
23. Yan Y, Andriole GL, Humphrey PA, et al. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors. Cancer 2002;95:1239-46.
24. Zlotta AR, Noel JC, Fayt I, et al. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol 1999;161:792-8.
25. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
26. Esrig D, Elmajian D, Groshen S, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994;331:1259-64.
27. Esrig D, Spruck CI, Nichols PW. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am J Pathol 1993;143:1389-97.
28. Lipponen P, Aaltomaa S, Eskelinen M, et al. Expression of p21WAF1/Cip1 protein in transitional cell bladder tumours and its prognostic value. Eur Urol 1998;34:237-43.
29. Liukkonen T, Liponen P, Raitanen M, et al. Evaluation of p21WAF1/Cip1 and cyclin D1 expression in the progression of superficial bladder cancer. Urol Res 2000;28:285-92.
30. Makri D, Schulz WA, Grimm MO, et al. WAF1/Cip1 p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines. Int J Oncol 1998;12:621-8.
31. Sgambato A, Migaldi M, Faraglia B, et al. Loss of p27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Cancer Res 1999;59:3245-50.
32. Stein JP, Ginsberg DA, Grossfeld GD, et al. Effect of p21WAF1/Cip1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 1998;14:1072-9.
33. Millán-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000;164:680-4.
34. Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003;169:1291-4.
35. Ali-El-Dein B, Sarhan O, Hinev A, et al. Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index. BJU Int 2003;92:393-9.